Effect of diet and fluvastatin treatment on the serum lipid profile of kidney transplant, diabetic recipients: A 1-year follow up

Transplant International

Volumn 11, Issue SUPPL. 1, 1998, Pages

  Foldes K ^a   Maklary E ^b   Vargha, P ^a   Janssen, J ^a   Jaray J ^a   Perner, F ^a   Gero L ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b National Institute of Cardiology Budapest   (Hungary)

Author keywords

Cyclosporin; Dislipidaemia; Fluvastatin; Posttransplant diabetes mellitus; Renal transplantation

Indexed keywords

CHOLESTEROL; FLUINDOSTATIN; HYPOCHOLESTEROLEMIC AGENT; INDOLE DERIVATIVE; LIPOPROTEIN; MONOUNSATURATED FATTY ACID;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; DIABETES MELLITUS; DIET; FEMALE; FOLLOW UP; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

ADULT; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; DIABETES MELLITUS; DIET; FATTY ACIDS, MONOUNSATURATED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDOLES; KIDNEY TRANSPLANTATION; LIPOPROTEINS; MALE; MIDDLE AGED;

EID: 0031614437     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1998.tb01198.x     Document Type: Article

References (14)

1. Brown JH, Anwar N, Short CD (1993) Serum lipoprotein(a) in renal transplant recipients receiving cyclosporin monotherapy. Nephrol Dial Transplant 8: 863-867
2. Castelao AM, Grino JM, Andres E, Gilvernet S, Seron D, Castineiras MJ (1993) HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation. Transpl Proc 25: 1043-1046
3. Dimény E (1994) Metabolic factors and outcome of organ transplantations. Scand J Urol Nephrol Suppl 159: 1-74
4. Dimény E, Fellström B, Larsson E, Tufveson G, Lithell H (1993) Chronic vascular rejection and hyperlipoproteinaemia in renal transplant patients. Clin Transpl 7: 482-490
5. Drueke TB, Abdulmassih Z, Lacour B, Bader C, Chevalier A, Kreis H (1991) Atherosclerosis and lipid disorders after renal transplantation. Kidney Int 31: 24-28
6. Hill MN, Grossman RA, Feldman HI, Hurwitz S, Dafoe DC (1991) Changes in causes of death after renal transplantation, 1966 to 1987. Am J Kidney Dis 17: 512-516
7. Ingulli E, Tejani A, Markell M (1993) The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclosporine era. Transplantation 55: 1029-1033
8. Isoniemi H, Tikkanen MJ, Ahonen J, Hayry P (1991) Renal allograft immunosuppression. IV Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations. Transpl Int 4: 130-135
9. Isoniemi HM, Ahonen J, Tikkanen NJ, Willebrandt EO van, Krogerus L, Eklund BH, Hockerstedt KV, Salmela KE, Hayri PJ (1993) Long-term consequences of different regimens for renal allografts. Transplantation 5: 494-499
10. Kasiske BL, Tortorice KL, Heim-Duthoy KL, Awni WM, Rao KV (1991) The adverse impact of cyclosporine on serum lipids in renal transplant recipients. Am J Kidney Dis 17: 700-707
11. Kuster GM, Drexel H, Bleisch JA, Rentsch K, Pei P, Binswanger U, Amann FW (1994) Relation of cyclosporine blood levels to adverse effects on lipoproteins. Transplantation 57: 1479-1483
12. Paul LC (1993) Chronic rejection of organ allografts. Magnitude of the problem. Transpl Proc 25: 2024-2025
13. Paul LC, Fellström B (1992) Chronic vascular rejection of the heart and kidney - have rational treatment options emerged? Transplantation 53: 1169-1179
14. Webb AT, Plant M, Reaveley DA, O'Donnel M, Luck VA, O'Connor B, Seed M, Brown EA (1992) Lipid and lipoprotein(a) concentrations in renal transplant patients. Nephrol Dial Transplant 7: 636-641